Please select a Capability in order to start your service request.
BD acquires KIESTRA Lab Automation BV
BD acquires Neomend
BD acquires Safety Syringes
BD acquires Cato Software Solutions
BD acquires Sirigen Group
BD acquires Medafor
BD acquires Rochester Medical
BD Acquires Alverix
BD acquires GenCell Biosystems
BD acquires CareFusion
BD acquires CRISI Medical Systems
BD acquires Cellular Research
BD acquires Medicon
BD acquires Liberator Medical
BD acquires Caesarea Medical Electronics
BD acquires C.R. Bard
BD acquires TVA Medical
Mergers and acquisitions (M&A) serve as an integral tool for BD in advancing its strategy of improving patient outcomes, reducing the cost of care, expanding access and enhancing the operations of our customers around the world. In recent years BD has completed dozens of tuck-in acquisitions including TVA Medical, Medafor, and Kiestra Lab Automation, and we continue to seek out attractive opportunities which align with the strategies of BD’s businesses and regions.
BD has developed leading capabilities in transactional structuring, execution, due diligence and integration. BD's Corporate Development team partners with our businesses, functions and regions to evaluate potential opportunities. All M&A opportunities should be directed to our Corporate Development team based out of our global headquarters in Franklin Lakes, New Jersey, USA through the website submission form.
BD examines and executes on M&A opportunities that are financially attractive and aligned with our strategy. This has proven to be, and remains, an important lever as we pursue our purpose of Advancing the World of Health— Vince Forlenza, Chairman
BD seeks inorganic opportunities that advance our long-term strategy through increasing patient access, driving better outcomes, managing system cost pressures, and improving health care safety. Directional criteria is provided below: